NasdaqCM - Nasdaq Real Time Price USD
Eupraxia Pharmaceuticals Inc. (EPRX)
3.8700
-0.0300
(-0.77%)
At close: May 13 at 4:00:00 PM EDT
3.7501
-0.12
(-3.10%)
After hours: May 13 at 5:40:44 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.19 | -0.2 | -0.75 | -0.81 |
| Low Estimate | -0.22 | -0.24 | -0.95 | -1.14 |
| High Estimate | -0.14 | -0.14 | -0.51 | -0.58 |
| Year Ago EPS | -- | -- | -0.78 | -0.75 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.17 | -0.13 | -0.16 | -0.17 |
| EPS Actual | -- | -- | -0.23 | -0.21 |
| Difference | -- | -- | -0.07 | -0.04 |
| Surprise % | -- | -- | -46.00% | -26.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.19 | -0.2 | -0.75 | -0.81 |
| 7 Days Ago | -0.22 | -0.24 | -0.94 | -0.63 |
| 30 Days Ago | -0.22 | -0.24 | -0.94 | -0.63 |
| 60 Days Ago | -0.2 | -0.22 | -0.72 | -0.63 |
| 90 Days Ago | -0.19 | -0.2 | -0.62 | -0.35 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EPRX | -- | -- | 3.41% | -8.44% |
| S&P 500 | 13.17% | 3.05% | 8.05% | 13.75% |
Upgrades & Downgrades
| Initiated | Rodman & Renshaw: Buy | 11/14/2024 |
Related Tickers
MDNAF Medicenna Therapeutics Corp.
0.7810
+1.92%
ACOG Alpha Cognition Inc.
6.91
-7.12%
MSCL.TO Satellos Bioscience Inc.
0.6700
+4.69%
MBCOF Marvel Biosciences Corp.
0.0601
-10.96%
EMBT Ember Therapeutics, Inc.
0.0001
0.00%
ESLA Estrella Immunopharma, Inc.
1.0301
+4.05%
DSGN Design Therapeutics, Inc.
3.5700
-1.38%
MSCLF Satellos Bioscience Inc.
0.4580
+0.11%
INDP Indaptus Therapeutics, Inc.
0.4400
+8.32%
CNTX Context Therapeutics Inc.
0.8200
+5.14%